Esprit will pay Depomed a $50 million license fee and 15%-to-25% royalties on net sales.Esprit Pharma, an East-Brunswick-based pharmaceutical company, has acquired exclusive rights to market and ...
Depomed, Inc. has received approval from the United States Food and Drug Administration (FDA) for Proquin XR, a once-daily, extended-release formulation of ciprofloxacin hydrochloride for the ...
May 26, 2005 — The U.S. Food and Drug Administration has approved an extended-release tablet formulation of ciprofloxacin HCl with a favorable adverse event profile for the treatment of uncomplicated ...
Co and Watson Pharmaceuticals (WPI) announces that they have entered into a co-promotion agreement for ProQuin XR, Depomed's extended release formulation of ciprofloxacin hydrochloride for the ...
When South Korean President Yoon Suk Yeol cited claims of election hacking and "anti-state" pro-North Korean sympathisers as justification for imposing a short-lived martial law, right-wing YouTuber ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results